         Rona M Smith* 1,2 , Rachel B Jones* 1,2 , MaryJane Guerry 1,2 , Simona Laurino 1,2 , Fausta Catapano 1,2 , Afzal Chaudhry 1,2 , Kenneth GC Smith 1,2,3 , David RW Jayne 1,2 .      1 Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge UK 2 Department of Medicine, University of Cambridge School of Clinical Medicine 3 Cambridge Institute for Medical Research, University of Cambridge School of Clinical Medicine   Rituximab maintenance therapy for ANCA vasculitis  ! rituximab, vasculitis, ANCA, maintenance, therapy, relapse, B cell   Dr Rona Smith Vasculitis and Lupus Clinic, Addenbrooke’s Hospital Cambridge, Hills Road, Cambridge, CB2 0QQ, UK Tel 00 44 (0) 1223 336819 Fax 00 44 (0) 1223 568796 Full Length Arthritis & Rheumatism DOI 10.1002/art.34583 © 2012 American College of Rheumatology Received: May 14, 2011; Revised: Apr 20, 2012; Accepted: Jun 07, 2012 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as an ‘Accepted Article’, doi: 10.1002/art.34583